BRIAN BROWN: Open Payments
NPI 1952801169 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,282 in 74 payments from 18 companies in 2025. Trend: 2023 $1,165 · 2024 $1,366 · 2025 $1,282
Food & beverage: $1,282
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $283 |
| ABBVIE INC. | 18 | $202 |
| PFIZER INC. | 11 | $178 |
| Astellas Pharma US Inc | 4 | $86 |
| Phathom Pharmaceuticals, Inc. | 4 | $76 |
| Neurocrine BioSciences, Inc. | 2 | $71 |
| Axsome Therapeutics, Inc. | 2 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Antares Pharma, Inc. | 2 | $41 |
Products named: Wegovy, NURTEC ODT, Ozempic, UBRELVY, Veozah, VOQUEZNA, QULIPTA, INGREZZA.
Industry payments across TN — which companies pay providers there.
